| Company Name |
Beryl Drugs Ltd |
| Face Value |
10 |
| BSE Code |
524606 |
| Year End |
202603 |
| Full Year |
| Equity (Rs.Cr.) |
5.07 |
| B.V. Rs. |
19.40 |
| Sales Rs. Cr. |
18.82 |
| NP Rs. Cr. |
0.42 |
| NP Var% |
-27.00 |
| Div% |
0.00 |
| CPS Rs. |
3.80 |
| EPS Rs. |
0.80 |
| Traded Value(Rs.Lakhs) |
0.59 |
| 52 Week High |
28.00 |
| 52 Week Low |
16.00 |
| Price BSE |
24.00 |
| Price NSE |
0.00 |
| Market Capital(Rs. Cr.) |
12.11 |
| P/C Ratio |
6.30 |
| P/E Ratio |
28.70 |
| Price Vs.BV |
1.24 |
| Year End |
202606 |
| Sales Rs. Cr. |
7.30 |
| NP Rs. Cr. |
0.22 |
| NP Var % |
946.00 |
| Year End |
202606 |
| Sales |
22.46 |
| OPM |
10.57 |
| NP |
0.34 |
| NP Var% |
169.07 |
| EPS |
1.23 |
| PE |
19.41 |
|
|